Prime Medicine Inc
NASDAQ:PRME
Income Statement
Earnings Waterfall
Prime Medicine Inc
Income Statement
Prime Medicine Inc
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
+35%
|
3
+273%
|
4
+29%
|
5
+29%
|
6
+20%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(27)
|
(84)
|
(98)
|
(117)
|
(138)
|
(117)
|
(137)
|
(156)
|
(175)
|
(205)
|
(214)
|
(224)
|
(227)
|
(205)
|
(210)
|
(209)
|
(210)
|
|
| Selling, General & Administrative |
(8)
|
(14)
|
(19)
|
(24)
|
(27)
|
(30)
|
(33)
|
(36)
|
(40)
|
(43)
|
(45)
|
(47)
|
(51)
|
(50)
|
(52)
|
(53)
|
(50)
|
|
| Research & Development |
(19)
|
(71)
|
(80)
|
(93)
|
(111)
|
(87)
|
(104)
|
(120)
|
(136)
|
(148)
|
(155)
|
(163)
|
(163)
|
(155)
|
(158)
|
(156)
|
(160)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(14)
|
(14)
|
(14)
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(27)
N/A
|
(84)
-213%
|
(98)
-17%
|
(117)
-19%
|
(138)
-18%
|
(117)
+16%
|
(137)
-17%
|
(156)
-14%
|
(175)
-13%
|
(205)
-17%
|
(213)
-4%
|
(224)
-5%
|
(226)
-1%
|
(202)
+11%
|
(207)
-2%
|
(204)
+1%
|
(204)
+0%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
12
|
(0)
|
(5)
|
(18)
|
(8)
|
(8)
|
(5)
|
(1)
|
(5)
|
(2)
|
0
|
0
|
4
|
7
|
4
|
5
|
6
|
|
| Total Other Income |
(90)
|
(81)
|
0
|
0
|
1
|
2
|
4
|
6
|
8
|
9
|
8
|
6
|
3
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(105)
N/A
|
(166)
-58%
|
(103)
+38%
|
(134)
-31%
|
(145)
-8%
|
(123)
+15%
|
(138)
-12%
|
(151)
-9%
|
(172)
-14%
|
(198)
-15%
|
(204)
-3%
|
(218)
-6%
|
(219)
-1%
|
(196)
+11%
|
(202)
-3%
|
(199)
+1%
|
(197)
+1%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
2
|
(1)
|
1
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(105)
|
(165)
|
(103)
|
(133)
|
(145)
|
(122)
|
(137)
|
(150)
|
(172)
|
(198)
|
(205)
|
(217)
|
(219)
|
(196)
|
(202)
|
(199)
|
(197)
|
|
| Net Income (Common) |
(118)
N/A
|
(184)
-56%
|
(126)
+31%
|
(158)
-25%
|
(171)
-8%
|
(142)
+17%
|
(151)
-7%
|
(158)
-4%
|
(173)
-9%
|
(198)
-14%
|
(205)
-3%
|
(217)
-6%
|
(219)
-1%
|
(196)
+11%
|
(202)
-3%
|
(199)
+1%
|
(197)
+1%
|
|
| EPS (Diluted) |
-1.25
N/A
|
-1.95
-56%
|
-1.33
+32%
|
-1.67
-26%
|
-1.81
-8%
|
-1.46
+19%
|
-1.69
-16%
|
-1.74
-3%
|
-1.88
-8%
|
-2.18
-16%
|
-1.95
+11%
|
-1.82
+7%
|
-1.83
-1%
|
-1.65
+10%
|
-1.54
+7%
|
-1.54
N/A
|
-1.22
+21%
|
|